CT scan study for pancreatic or liver bile cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how CT scans (detailed X-ray pictures) help diagnose pancreatic cancer or hepatobiliary (liver/bile duct) cancers. It may help your care team better decide what’s going on and plan next treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer or hepatobiliary cancer (hepatocellular carcinoma or intrahepatic cholangiocarcinoma)
- Your cancer is not “resectable” (it can’t be fully removed with surgery) and there is no distant spread (metastasis)
- Your cancer doctor has recommended chemotherapy for pancreatic cancer, or you’re being planned for definitive radiation for hepatobiliary cancer
- You must be well enough to do daily activities (ECOG performance status 0–1)
- You must be able to undergo CT scans with iodine contrast (and have no major heart problems or active severe infection)
- If you can get pregnant: you must use reliable birth control and not breastfeed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.
This study checks how well the LUM Imaging System can detect cancers of the esophagus, colon, or pancreas during the time you are preparing for surgery. It’s mainly meant to see if the scan works safely and clearly for doctors to find cancer areas.
This study tests whether a special PET scan (using [18F]FTT) can predict how well the standard GCD chemotherapy and immunotherapy combination will work for newly diagnosed bile duct cancer. The scan helps doctors see tumor activity before treatment.
This trial uses a new imaging agent called 64Cu-DOTA A2 to help see pancreatic cancer on a PET scan. It may help doctors find cancer that has spread, without the need for surgery.
This study uses a special CT scan called spectral CT to get more detailed pictures of the pancreas. If you have already had this type of scan, the researchers will review it to learn more about your pancreatic health.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.